Washington [US], November 6 (ANI): The Medical College of Georgia scientists have early evidence that HBI-002, a low-dose oral compound developed by Hillhurst Biopharmaceuticals and already in early-stage trials for sickle cell disease, can safely reduce oxidative stress and inflammation in
New Delhi [India], Jan 13 (ANI): A team led by a scientist from the Indian Council of Medical Research - National Institute of Nutrition (ICMR-NIN) have established a role of lead as a risk factor in the development of neurodegenerative diseases.